One Year of Prospera Hearth with DQS

Advancing ADPKD Diagnosis and Management: A Case-Based Approach to Understanding the Latest Guideline & the Role of Genetic Testing

Renasight - Variants of Uncertain Significance Video

This brief video will introduce you to genetic variant classification, with a focus on variants of uncertain significance (VUSes)

ISHLT 2025 clinical use of DQS Brent Lampert

Dr Lampert from Ohio State shares three key scenarios where DQS has added clinical value above and beyond traditional dd-cfDNA testing.

ISHLT 2025 Trifecta Heart with DQS Phil Halloran

Dr Phil Halloran walks through initial data from the Trifecta Heart study highlighting the correlation between dd-cfDNA fraction and DQS with MMDx.

ISHLT 2025 clinical use of DQS Roopa Rao

Dr Roopa Rao from IU Health shares her experience with 2 unique cases where Prospera Heart with DQS was key to their clinical care.

ISHLT 2025 DQS Background Michael Olympios

Natera's medical director, Michael Olympios, introduces the concept of donor quantity score and highlights key supportive evidence.

ISHLT 2025 - Enhancing overall dd-cfDNA testing accuracy in heart transplantation using fraction and donor quality score(DQS)

ISHLT 2025- Expanding our Understanding of dd-cfDNA in providing Lung Transplant Personalized Care

Clinical Conundrum: When cDNA & Biopsy Don't Agree

What is the Natera Patient Portal?

Does insurance cover the Prospera test?